Cargando…

Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment

Although many diseases in which reactive oxygen species (ROS) and free radicals are involved in their pathogenesis are known, and antioxidants that effectively capture ROS have been identified and developed, there are only a few diseases for which antioxidants have been used for treatment. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Shichiri, Mototada, Suzuki, Hiroshi, Isegawa, Yuji, Tamai, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899923/
https://www.ncbi.nlm.nih.gov/pubmed/36777080
http://dx.doi.org/10.3164/jcbn.22-61
_version_ 1784882739043893248
author Shichiri, Mototada
Suzuki, Hiroshi
Isegawa, Yuji
Tamai, Hiroshi
author_facet Shichiri, Mototada
Suzuki, Hiroshi
Isegawa, Yuji
Tamai, Hiroshi
author_sort Shichiri, Mototada
collection PubMed
description Although many diseases in which reactive oxygen species (ROS) and free radicals are involved in their pathogenesis are known, and antioxidants that effectively capture ROS have been identified and developed, there are only a few diseases for which antioxidants have been used for treatment. Here, we discuss on the following four concepts regarding the development of applications for disease treatment by regulating ROS, free radicals, and lipid oxidation with the findings of our research and previous reports. Concept 1) Utilization of antioxidants for disease treatment. In particular, the importance of the timing of starting antioxidant will be discussed. Concept 2) Therapeutic strategies using ROS and free radicals. Methods of inducing ferroptosis, which has been advocated as an iron-dependent cell death, are mentioned. Concept 3) Treatment with drugs that inhibit the synthesis of lipid mediators. In addition to the reduction of inflammatory lipid mediators by inhibiting cyclooxygenase and leukotriene synthesis, we will introduce the possibility of disease treatment with lipoxygenase inhibitors. Concept 4) Disease treatment by inducing the production of useful lipid mediators for disease control. We describe the treatment of inflammatory diseases utilizing pro-resolving mediators and propose potential compounds that activate lipoxygenase to produce these beneficial mediators.
format Online
Article
Text
id pubmed-9899923
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher the Society for Free Radical Research Japan
record_format MEDLINE/PubMed
spelling pubmed-98999232023-02-11 Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment Shichiri, Mototada Suzuki, Hiroshi Isegawa, Yuji Tamai, Hiroshi J Clin Biochem Nutr Review Although many diseases in which reactive oxygen species (ROS) and free radicals are involved in their pathogenesis are known, and antioxidants that effectively capture ROS have been identified and developed, there are only a few diseases for which antioxidants have been used for treatment. Here, we discuss on the following four concepts regarding the development of applications for disease treatment by regulating ROS, free radicals, and lipid oxidation with the findings of our research and previous reports. Concept 1) Utilization of antioxidants for disease treatment. In particular, the importance of the timing of starting antioxidant will be discussed. Concept 2) Therapeutic strategies using ROS and free radicals. Methods of inducing ferroptosis, which has been advocated as an iron-dependent cell death, are mentioned. Concept 3) Treatment with drugs that inhibit the synthesis of lipid mediators. In addition to the reduction of inflammatory lipid mediators by inhibiting cyclooxygenase and leukotriene synthesis, we will introduce the possibility of disease treatment with lipoxygenase inhibitors. Concept 4) Disease treatment by inducing the production of useful lipid mediators for disease control. We describe the treatment of inflammatory diseases utilizing pro-resolving mediators and propose potential compounds that activate lipoxygenase to produce these beneficial mediators. the Society for Free Radical Research Japan 2023-01 2022-10-18 /pmc/articles/PMC9899923/ /pubmed/36777080 http://dx.doi.org/10.3164/jcbn.22-61 Text en Copyright © 2023 JCBN https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Review
Shichiri, Mototada
Suzuki, Hiroshi
Isegawa, Yuji
Tamai, Hiroshi
Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
title Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
title_full Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
title_fullStr Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
title_full_unstemmed Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
title_short Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
title_sort application of regulation of reactive oxygen species and lipid peroxidation to disease treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899923/
https://www.ncbi.nlm.nih.gov/pubmed/36777080
http://dx.doi.org/10.3164/jcbn.22-61
work_keys_str_mv AT shichirimototada applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment
AT suzukihiroshi applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment
AT isegawayuji applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment
AT tamaihiroshi applicationofregulationofreactiveoxygenspeciesandlipidperoxidationtodiseasetreatment